Neuropathic pain: from mechanisms to treatment

NB Finnerup, R Kuner, TS Jensen - Physiological reviews, 2021 - journals.physiology.org
Neuropathic pain caused by a lesion or disease of the somatosensory nervous system is a
common chronic pain condition with major impact on quality of life. Examples include …

Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment

J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms

TS Jensen, NB Finnerup - The Lancet Neurology, 2014 - thelancet.com
Allodynia (pain due to a stimulus that does not usually provoke pain) and hyperalgesia
(increased pain from a stimulus that usually provokes pain) are prominent symptoms in …

Cisplatin and oxaliplatin: our current understanding of their actions

IA Riddell, SJ Lippard - Met. Ions Life Sci, 2018 - degruyter.com
Following the serendipitous discovery of the anticancer activity of cisplatin over 50 years
ago, a deep understanding of the chemical and biochemical transformations giving rise to its …

[HTML][HTML] Platinum-induced neurotoxicity: A review of possible mechanisms

O Kanat, H Ertas, B Caner - World journal of clinical oncology, 2017 - ncbi.nlm.nih.gov
Patients treated with platinum-based chemotherapy frequently experience neurotoxic
symptoms, which may lead to premature discontinuation of therapy. Despite discontinuation …

A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration

AJM Beijers, F Mols, G Vreugdenhil - Supportive Care in Cancer, 2014 - Springer
Purpose The aim of this study was to systematically review the literature on the influence of
oxaliplatin administration (eg cumulative dose, dose intensity, number of cycles and …

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

JA Sprowl, G Ciarimboli… - Proceedings of the …, 2013 - National Acad Sciences
Oxaliplatin is an integral component of colorectal cancer therapy, but its clinical use is
associated with a dose-limiting peripheral neurotoxicity. We found that the organic cation …

An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1. 6 in peripheral pain pathways

JR Deuis, K Zimmermann, AA Romanovsky… - Pain®, 2013 - Elsevier
Cold allodynia, pain in response to cooling, occurs during or within hours of oxaliplatin
infusion and is thought to arise from a direct effect of oxaliplatin on peripheral sensory …

[HTML][HTML] Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase IIa clinical trial

J Bruna, S Videla, AA Argyriou, R Velasco, J Villoria… - …, 2018 - Elsevier
This trial assessed the efficacy of MR309 (a novel selective sigma-1 receptor ligand
previously developed as E-52862) in ameliorating oxaliplatin-induced peripheral …

Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel

L Ventzel, AB Jensen, AR Jensen, TS Jensen… - Pain, 2016 - journals.lww.com
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer
therapy. This study evaluates symptoms of CIPN and CIPN-related pain and its influence on …